AIM ImmunoTech Inc. (AIM) Institutional Ownership

Ownership Summary

AIM ImmunoTech Inc. (NYSE:AIM) currently has 5 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• The percentage of AIM ImmunoTech owned by institutions changed from 5.1% in September 2025 to 0.9% in December 2025, marking a slight down trend.
• On a quarter-over-quarter basis, institutional holdings shifted by 0.42%, with a year-over-year a decrease of 86.11% in the count of filers.
• The latest 13F cycle for AIM ImmunoTech reveals that of 5 total investors, 1 funds grew their exposure, whereas 0 reduced theirs and 4 made no changes.
• The total number of shares held by institutions in AIM ImmunoTech increased to 18.02K as of December 2025, a net change of up by 75 shares quarter on quarter, and down 28.45K shares year over year.
• With 17.50K shares, VANGUARD GROUP INC commands the largest institutional position in AIM ImmunoTech as of December 31, 2025, equating to 0.84% of the company.
• Among the most significant buyers of AIM ImmunoTech during December 2025 were UBS Group AG (75).
• The top 5 institutional holders of AIM ImmunoTech for the quarter ending December 2025 included VANGUARD GROUP INC (17.50K), UBS Group AG (379), Community Bank, N.A. (132), HOEY INVESTMENTS, INC (10), Farther Finance Advisors, LLC (1).